Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001092307-03-000109
Filing Date
2003-02-13
Accepted
2003-02-12 18:43:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 ANNUAL FILING osipharm.txt SC 13G 16770
  Complete submission text file 0001092307-03-000109.txt   18749
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 03556034
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

EIN.: 13294498 | State of Incorp.: I8